Arcutis grants 57,000 RSUs under Nasdaq Rule 5635(c)(4)
Arcutis Biotherapeutics announced the grant of an aggregate 57,000 restricted stock units (RSUs) under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.